Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
34.5 GBX | -1.43% | -2.82% | +122.58% |
Mar. 14 | Horizonte subsidiary hit with debt injunction | AN |
Mar. 14 | Renalytix plc's KidneyIntelX Included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+122.58% | 52.99M | |
+9.84% | 23.71B | |
-34.52% | 3.23B | |
+12.64% | 1.79B | |
+0.27% | 1.67B | |
+35.60% | 1.38B | |
-3.60% | 1.11B | |
-20.26% | 915M | |
-4.34% | 738M | |
-14.00% | 716M |
- Stock
- Equities
- Stock Renalytix Plc - London S.E.
- News Renalytix Plc
- Renalytix Says Kidney Disease Test Valuable as Risk Decision Tool in Primary Care Setting